Analysis and Development Sample Clauses

Analysis and Development. (a) In the event that the Materials or End-Product are not suitable for a Project or Projects (“Tentative Projects”) as determined by a relevant health authority and require further testing, processing or modification in accordance with applicable laws and regulations, the following provisions shall apply: (i) Filament shall, [*****], subject the Materials or End-Product to the tests, processing and modification recited, contemplated by or required to carry out the Tentative Projects. Ownership of all Intellectual Property resulting from the testing, processing and modification of the Materials or End-Product shall vest in Filament upon creation. (ii) Filament shall provide Psyence will all certificates of analysis and additional information and documentation as may be required to commence the Tentative Projects, including updated information and documentation as mentioned in Section 2.1(c). (iii) In the event that Filament is unsuccessful in its attempts and the Materials or End-Product remain unsuitable for the Tentative Projects or fails to deliver the information/documentation required in sub-section (ii) above, then Psyence shall be entitled to [*****] whereupon that Tentative Project(s) shall be excluded from this Agreement and this Agreement shall be deemed to have been terminated in respect of that Tentative Project(s).

Analysis and Development. (a) In the event that the Licensed Products are not suitable for a Trials ("Tentative Trials") as determined by a relevant health authority and require further testing, processing or modification in accordance with applicable laws and regulations, the following provisions shall apply: (i) PSYUK shall, at its own cost, subject the Licensed Products to the tests, processing and modification recited, contemplated by or required to carry out the Tentative Trials. Ownership of all Intellectual Property resulting from the testing, processing and modification of the Licensed Products shall vest in PSYUK upon creation. (ii) PSYUK shall provide PBM will all certificates of analysis and additional information and documentation as may be required to commence the Tentative Trials, including updated information and documentation as mentioned in Section 4.1(c). (iii) In the event that PSYUK is unsuccessful in its attempts and the Licensed Products remain unsuitable for the Tentative Trials or fails to deliver the information/documentation required in sub-section (ii) above, then, at PBM's election, PBM shall be entitled to a refund of the Development Milestone Payment paid in respect of that Tentative Trial in accordance with Section 5.2(a).

Analysis and Development. Borrower has (i) begun analyzing the operations of Borrower and it subsidiaries and affiliates that could be adversely affected by failure to become Year 2000 compliant (that is, that computer applications, imbedded microchips and other systems will be able to perform date-sensitive functions prior to and after December 31, 1999), and (ii) developed a plan for becoming Year 2000 compliant in a timely manner, the implementation of which is on schedule in all material respects. Borrower reasonably believes that it will become Year 2000 compliant for its operations and those of its subsidiaries and affiliates on a timely basis except to the extent that a failure to do so could not reasonably be expected to have a material adverse effect upon the financial condition of Borrower.